Roche Holding (SWX:ROG) experienced a 14% increase in share price over the last quarter, driven in part by several key ...
Oxford BioTherapeutics (OBT) has lined up another big pharma partner for its drug discovery platform, agreeing to work with ...
Roche and Oxford BioTherapeutics (OBT) have entered into a partnership worth over $1bn to discover new antibody-based ...
Pharmaceutical Technology on MSN13d
Oxford BioTherapeutics and Roche link on antibody cancer treatmentsOBT has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment.
Oxford BioTherapeutics (OBT) has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment. The partnership will leverage OBT's OGAP-Verify discovery ...
Oxford BioTherapeutics has partnered with Roche to discover novel potentially first-in-class antibody-based therapeutics for the treatment of cancer.
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for ...
Roche, which put billions on the line a year ago across several ADC pacts, kicked off 2025 by returning to Innovent Biologics ...
Oxford BioTherapeutics inks multi-year collaboration with Roche to discover novel targets for antibody-based therapeutics to treat cancer: Oxford, UK Thursday, March 20, 2025, 17: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback